U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5996568

Process For Propelling Foodstuffs or the Like into a Crowd

A method of launching foodstuffs into a crowd for promotional and entertainment purposes.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 544/385 - Plural chalcogens bonded directly to piperazine ring carbons


Subclass of Class 544 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein at least two chalcogen atoms (i.e., oxygen,
No. of patents: 110
Last issue date: 05/08/2012


1      
NumberTitleIssue Date
8173809Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
The present invention provides cysteine and cystine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of ...
05/08/2012
7709639Catalysis of diketopiperazine synthesis
Provided is a method for the synthesis of N-protected bis-3,6-[4-aminobutyl]-2,5-diketopiperazine including the step of heating a solution of ε-amino protected lysine in the presence of a catalyst selected from the group consisting of sulfuric acid, phosphoric acid...
05/04/2010
7288545Piperazinedione compounds
This invention relates to a method for treating an angiogenesis-related disease. The method includes administering to a subject in need thereof an effective amount of a piperazinedione compound having the formula:
10/30/2007
7132424Monocyclic derivatives as matrix metalloproteinase inhibitors
This invention provides compounds defined by Formula I R1-Q-D-(V1)m—R2I or a pharmaceutically acceptable salt thereof, wherein R1, Q, D, V1, m,...
11/07/2006
7067693Deeply reduced oxidation catalyst and its use in preparing N-(phosphonomethyl) glycine compounds
This invention relates to an improved catalyst, comprising a carbon support having a noble metal at its surface, for use in catalyzing liquid phase oxidation reactions, especially in an acidic oxidative environment and in the presence of solvents, reactants, interme...
06/27/2006
6972289Cell division inhibitor and a production method thereof
The present invention relates to a cell division inhibitor comprising various dehydrodiketopiperazines such as dehydrophenylahistin, or analogs thereof as an active ingredient, and a dehydrogenase and a method for producing the same inhibitor. ...
12/06/2005
6967202Method of synthesizing diketopiperazines
The invention provides a method of synthesizing a diketopiperazine of the formula: wherein: R1 is —CH2COR3, or —CH2CH2COR
11/22/2005
6951861Chemical compounds
The invention relates to piperazine derivatives, to processes for their preparation, to pharmaceutical compositions containing them, and to their medical use. The novel compounds are antagonists of tachykinins, including substance P and other neurokinins. ...
10/04/2005
6900213Bisaryl derivatives having FSH modulatory activity
The invention relates to bisaryl derivatives of the formula I, wherein (R,R) is selected from (H,H), O, (H,CH3), (H,OH) and (H,CN); Ar is substituted phenyl and A is a group of formula II, III, IV ...
05/31/2005
6818645Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
This invention relates to compounds which are generally muscarinic M2/M3 receptor antagonists and which are represented by Formula I: wherein X, Y, and Z are O, S, or NR4, and the other substituents are as d...
11/16/2004
6642225Diazacycloalkanedione derivatives
Compounds of formula I ##STR1## wherein R is carboxy, esterified carboxy or amidated carboxy; R1 and R3 are independently lower alkyl, (hydroxy, lower alkoxy, amino, acylamino, mono- or di-lower alkylamino or mercapto)-lower alkyl, ...
11/04/2003
6525042Sulfonyl derivatives
Sulfonyl derivatives represented by general formula (I), salts of the same, and solvates of both: and application of them as drugs: [wherein R1 is hydrogen, hydroxyl, nitro or the like; R2 and R3 are each independently hyd...
02/25/2003
6387389Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use
The present invention provides sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines, pharmaceutical compositions comprising the same, and a method of using such sustained-r...
05/14/2002
6376708Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts
This invention is directed to a process for making a salt of a carboxylic acid. The process comprises contacting a catalyst with an alkaline mixture comprising a primary alcohol. In one embodiment, for example, the catalyst comprises a metal support (pref...
04/23/2002
6369063Selective factor Xa inhibitors
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders....
04/09/2002
6271232Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
Novel inhibitors of metalloproteases, in particular collagenase-1 and stromelysin-1, are disclosed. Such compounds are useful in pharmaceutical compositions and methods for treating or controlling disease states or conditions which involve tissue breakdow...
08/07/2001
6211183Selective factor Xa inhibitors
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders....
04/03/2001
6204268Selective factor Xa inhibitors
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders....
03/20/2001
6153753Method of preparing amino carboxylic acids
Process for the preparation of an N-acyl amino carboxylic acid by means of a carboxymethylation reaction. In this reaction, a reaction mixture is formed which contains a base pair, carbon monoxide, hydrogen and an aldehyde with the base pair comprising a ...
11/28/2000
6107274Piperazines as inhibitors of fructose-1,6-bisphosphatase (FBPase)
Compounds of formula A are disclosed: ##STR1## wherein R1 is aralkyl or cycloalkyl; R2 is cycloalkylmethyl, alkyl, or aralkyl; R3 is hydrogen, alkyl, substituted phenyl (including p-phenoxy-phenyl), or fluorene; R
08/22/2000
6020373Chelate derivatives as protectors against tissue injury
Derivatives useful in the protection of living organisms against damage due to free radical reactions derived from methoxypolyethylene glycols (MPEG), which are modified by chemically attaching chelating groups in an amide or amine linkage to the nonmethy...
02/01/2000
5994543Antibiotic bravomicins
A novel class of antibiotics, designated bravomicins, is obtained by fermentation of a strain of Micromonospora polytrota. Six bioactive compounds, designated bravomicins A, B, C, D, E and F, are obtained and found to be useful in the treatment of a wide ...
11/30/1999
5990112Inhibitors of metalloproteases pharmaceutical compositions comprising same and methods of their use
Novel inhibitors of metalloproteases are disclosed. Such compounds are useful in pharmaceutical compositions and methods for treating or controlling disease states or conditions which involve tissue breakdown, such as rheumatoid arthritis....
11/23/1999
5977359Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
The invention relates to compounds of the formula ##STR1## in which: A is a divalent radical selected from: A1) --O--CO-- A2) --CH2 --O--CO-- A3) --O--CH2 --CO-- A4) --O--CH2 --CH
11/02/1999
5935955Pharmaceutical piperazine compounds
A piperazinedione of general formula (I): ##STR1## wherein R1 is selected from hydrogen; a group of formula --(NH)t --COR3 wherein t is 0 or 1 and R3 is an organic substituent as defined herein; a group of formu...
08/10/1999
5932579Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
Novel inhibitors of metalloproteases, in particular collagenase-1 and stromelysin-1, are disclosed. Such compounds are useful in pharmaceutical compositions and methods for treating or controlling disease states or conditions which involve tissue breakdow...
08/03/1999
5919777Compounds with growth hormone releasing properties
The present invention relates to novel compounds of the general formula I ##STR1## which can be used for treating medical disorders resulting from a deficiency in growth hormone....
07/06/1999
5902812Pharmaceutical piperazine compounds
Diketopiperazines of formula (A): ##STR1## wherein each of R1 to R8 is H or an organic radical as described herein and the pharmaceutically acceptable salts thereof have activity as inhibitors of plasminogen activator inhibitor....
05/11/1999
5891877Pharmaceutical compounds
Diketopiperazines of the formula ##STR1## where one or both of R1 and R2, which are different, are chosen from X and a phenyl group substituted by X, C(O)X, OC(O)CH2 X, OCH2 CH2 X, CH2...
04/06/1999
58771742,3-diketopiperazine derivatives or their salts
The present invention relates to a 2,3-diketopiperazine derivative or a salt thereof, which has inhibitory effect on platelet aggregation because of glycoprotein IIb/IIIa receptor antagonism and hence is useful as a prophylactic and therapeutic agent for ...
03/02/1999
5869554Polycarbonate compositions comprising hindered amine light stabilizers and ultraviolet light absorbers
Weatherable polycarbonate compositions (formulations or blends) comprise at least one of a piperazinone and piperazine dione based HALS, and at least one of a benzotriazole, benzophenone, triazine, oxanilide, and cyanoacrylate based UVA. The combination o...
02/09/1999
5861400Pharmaceutical compounds
Piperazine derivatives of the formula ##STR1## their esters and salts are useful as modulators of multiple drug resistance....
01/19/1999
5856486Polycarbonate compositions comprising hindered amine light stabilizers
The instant invention relates to weatherable polycarbonate compositions (formulations or blends) comprising piperazinone or piperazine dione based HALS. These piperazinone or piperazine dione based HALS impart photostability to the polycarbonate formulati...
01/05/1999
5852018Pharmaceutical piperazine compounds
Piperazine derivatives of formula (A): ##STR1## wherein -------- denotes an optional bond, provided that either ----a---- and ----c---- are both bonds and ----
12/22/1998
5824677Substituted amino alcohol compounds
Disclosed are compounds having a straight or branched aliphatic hydrocarbon structure of formula I: ##STR1## In formula I, n is an integer from one to four and m is an integer from four to twenty. Independently, R1 and R2 are hy...
10/20/1998
5807856Alpha 1a adrenergic receptor antagonist
This invention relates to certain novel compounds and derivatives thereof, their synthesis, and their use as selective alpha 1a adrenergic receptor antagonists. One application of these compounds is in the treatment of benign prostatic hyperplasia. These ...
09/15/1998
5750530Pharmaceutical diketopiperazine compounds
A diketopiperazine of formula (I): ##STR1## wherein each of R7 and R8 which may be the same or different; is hydrogen or a nitro group; Y is ##STR2## --O-- or --S--, wherein each of R9 and R10 which ma...
05/12/1998
5728830Farnesyltransferase inhibitor
The present invention relates to a farnesyltransferase inhibitor and an antitumor agent comprising, as an active ingredient, a piperazinedione derivative represented by formula (I): ##STR1## wherein R1 and R2 independently repre...
03/17/1998
5707993Glycine anhydride dimethylol as a biocide and preservative
The use of glycine anhydride dimethylol, also known as 1,4-bis(hydroxymethyl)-2,5-piperazinedione, comprising the formula ##STR1## to kill microorganisms present in or on a host substance and to preserve products susceptible to contamination by a var...
01/13/1998
5700804Pharmaceutical compounds
Diketopiperazines of the formula: ##STR1## where each of R1 to R10, which may be the same or different, is independently selected from the group consisting of hydrogen, C1 -C6 alkyl unsubstituted or substit...
12/23/1997
1      
 
Sign InRegister
Username  
Password   
forgot password?